News Wire

New research indicates that the prevalence of arthritis in the United States has been substantially underestimated, especially among adults younger than 65 years of age. The findings, published in the journal Arthritis & Rheumatology, indicate that research is needed to better monitor arthritis prevalence…
Changing the prices of seven foods, including fruits, vegetables, and sugar-sweetened beverages, could reduce deaths due to stroke, diabetes, and cardiovascular disease and address health disparities in the United States, according to a study led by Tufts University researchers. In the study, published…
The FDA has approved the first implantable lens that can be adjusted after cataract surgery using ultraviolet light to improve patients’ vision, possibly eliminating the need for eyeglasses or contacts. The Light Adjustable Lens (RxSight Inc.) is made of a unique material that reacts to ultraviolet…
Aetna wants to combine with CVS Health and the Cleveland Clinic is teaming up with Oscar Health. Two developments that Managed Care’s covered (here and here). The New York Times today says that the joining of health plans, providers, and national drug store chains reflects the growing uncertainty…
Funding for the Children’s Health Insurance Program (CHIP) is in danger of running out in nearly a dozen states, the Washington Post reports. About nine million children are insured through CHIP, and an additional 370,000 pregnant women also get their coverage through the program. The crisis results…
The FDA has approved the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of the three or more drugs included in standard HIV treatment. Juluca (dolutegravir/rilpivirine, ViiV Healthcare) is a fixed-dose tablet…
Cytokinetics will scrap its late-stage drug to treat amyotrophic lateral sclerosis (ALS) after its key phase 3 trial failed to meet primary endpoints. Shares of the stock plunged more than 33% following the announcement, according to a report on BioSpace. The company said it has suspended development…
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according by researchers at the Stanford University School of Medicine and the National Cancer Institute. The…
A new American Cancer Society (ACS) study calculates the contribution of several modifiable risk factors to cancer occurrence, expanding and clarifying the role of known risk factors, from smoking to low consumption of fruits and vegetables. The study finds more than four in 10 cancer cases and deaths…
Physicians at Kaiser Permanente in Southern California reduced the odds of prescribing an antibiotic for sinusitis by 22% using computer alerts to inform doctors when antibiotics may not be the best course of treatment, according to research published in the American Journal of Managed Care. The work…
Policymakers and insurers have been pushing people addicted to opioids into abstinence-based detox programs, but a new study concludes that methadone and similar drug-maintenance treatments save lives and money, Reuters reports. If the nearly 47,000 Californians who began treatment for opioid-use disorder…
The FDA has approved an 0.1-mg epinephrine auto-injector (Auvi-Q, kaléo), the first such device specifically designed for the treatment of life-threatening allergic reactions in infants and small children weighing 16.5 to 33 pounds who are at risk for or have a history of serious allergic reactions.…
Acorda Therapeutics, Inc., is discontinuing clinical development of its Parkinson’s disease treatment tozadenant after five people died of sepsis in late-phase trials. Acorda announced that it is immediately ending dosing of all participants enrolled in its tozadenant studies. The company made this…
Patients with cochlear implants that require frequent adjustments can now avoid long trips to distant specialists. The FDA has approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System (Cochlear Americas) through a telemedicine platform. The remote programming…
Obinutuzumab (Gazyva, Genentech) has won FDA approval for the initial treatment of advanced follicular lymphoma after improving patients’ survival in trials compared with rituximab-based regimens, the current standard of care. The FDA approved obinutuzumab in combination with chemotherapy, followed…

Pages